sufficient to complicate seriously any therapeutic regimen requiring salt restriction.
Information on the theoretical sodium content of BP and BPC preparations is readily available, but only one proprietary antacid preparation states the sodium content on its statutory product data sheet. To make this information freely available, we have measured the sodium content of 15 liquid and 13 tablet antacids which are in common use in our health district. The neutralising capacity of each antacid was also measured so that a comparison of in vitro neutralising capacity and sodium content can be made. 
Methods and results

Neutralising
Comment
Patients with hepatic or renal failure frequently require dietary sodium restriction to maintain fluid balance. Most such dietary regimens limit sodium consumption to about 40 mmol per day, but it is occasionally necessary to reduce this to 20 mmol per day.
Some antacids (see table, 1-4 and 16) contain such large amounts of sodium that the sodium consumed from that source would soon exceed the daily allowance of a 40 mmol/day regimen. Note that Synergel contains a significantly greater concentration of sodium than Liquid Gaviscon, but the manufacturer's maximum recommended dosage for their product is different, so that the daily sodium consumption from Liquid Gaviscon is more than twice that from Synergel. This factor may be of importance for tablet antacids, where, although the total sodium content per tablet is usually small in comparison with liquid antacids, the manufacturers frequently fail to indicate an upper limit on the number to be consumed (E).
The neutralising capacity of different antacids varies widely. Although Synergel contains a very high sodium concentration, it at least has the potential advantage of a high neutralising capacitywhereas Liquid Gaviscon (also high sodium) has a tiny neutralising capacity.
For some liquid preparations (see table, 5-12) sodium salts are present in chemically significant amounts as contaminants of the active ingredients, which may themselves have been prepared from other sodium salts. There is no designated limit of impurity with respect to sodium. Nevertheless, our results indicate that this contamination is present in quantities small enough to be clinically insignificant except if consumed in unusual quantities by patients on the strictest salt-free regimens.
Familial hypercholesterolaemia with alpha,-antitrypsin deficiency ol-Antitrypsin deficiency (PiZZ) has been recorded in association with pulmonary emphysema' and juvenile liver cirrhosis2 but not with genetically determined conditions. We report a patient with familial hypercholesterolaemia associated with obstructive lung disease with acl-antitrypsin deficiency PiZZ. Such an association has not been described.
Case report
A 54-year-old man presented with the sudden onset of hemiparesis and aphasia, which recovered progressively. For 15 years he had had chronic bronchitis, emphysema, and severe progressive exertional dyspnoea. At the age of 34 he had been told that his serum cholesterol concentration was raised and he had been treated initially with a diet and latterly with cholestyramine. Three years before admission he had had renal colic and a stone had been shown on intravenous pyelography. His father and his three brothers had all died suddenly in their 20s from an illness characterised by precordial pain, while both of his paternal aunts had died from cerebral thrombosis, one in her 20s, the other in her 50s. Examination showed many xanthelasmas, corneal arcus, and several xanthomas on both Achilles tendons. The thyroid was not palpable. The chest was barrel shaped, hyperresonant on percussion, with prolonged expiration and widespread rhonchi. A slightly tender liver was felt 2 cm below costal margin. Peripheral pulses were palpable, and the optic fundus showed arteriovenous nipping and slight arterial narrowing.
Investigations showed: haemoglobin 17 9 g/dl, packed cell volume 56 8 0', normal liver function tests, albumin 40-6 g/l, ml-globulin 0 7 g/l, M2-globulin 10 5 g/l, p-globulin 8-0 g/l, y-globulin 9 8 g/l, urate 0-24 mmol/l (4-1 mg/100 ml), cholesterol 8 66 mmol/l (377 mg/100 ml), triglycerides 1-13 mmol/l (100 mg/ml). 
